Published April 2026

CPAP Recall and Lung Cancer: Understanding the Connection

Medically reviewed by licensed healthcare professionals · Legally reviewed by mass tort litigation specialists · Last updated: April 2026

Lung cancer is among the most serious diagnoses associated with long-term use of recalled Philips CPAP, BiPAP, and ventilator devices. The mechanism is direct: degraded foam particles and toxic gases were delivered nightly into users' airways through the pressurized air stream. For heavy, long-term users, the cumulative exposure may be substantial.

The Pathway From Foam to Lung Cancer

The connection between Philips CPAP foam degradation and lung cancer risk begins with the chemical composition of the PE-PUR foam itself. Polyester-based polyurethane foam, when it degrades through heat, humidity, or ozone exposure, releases several categories of potentially carcinogenic compounds.

The key concern is diisocyanates — specifically toluene diisocyanate (TDI), which is a known respiratory sensitizer and an IARC Group 2B possible human carcinogen. TDI is a precursor chemical used in polyurethane foam manufacturing, and it can be released when the foam breaks down. Repeated exposure to TDI has been associated with occupational asthma and is being studied for its potential role in respiratory malignancies.

In addition to TDI, testing of recalled Philips devices found other VOCs in the airstream including diethylene glycol and several aldehydes — compounds with mutagenic properties at sufficient exposure levels. The concern is not a single high-dose exposure but chronic, repeated low-dose exposure during the hours of sleep each night — sometimes for years or decades.

Which Lung Conditions May Qualify

The personal injury track of the Philips recall settlement includes lung cancer as a qualifying condition. Claimants who developed lung cancer after years of recalled device use — and whose cancer cannot be adequately explained by other well-established risk factors alone — may have viable claims. The litigation also covers:

• Lung cancer (all histological types including adenocarcinoma, squamous cell, and small cell)
• Cancer of the trachea, bronchus, or airway
• Nasal or sinus cancer
• Head and neck cancers involving structures in the upper airway
• Serious, non-malignant lung diseases including pulmonary fibrosis linked to foam particle inhalation

The Role of Duration of Use

CPAP therapy for sleep apnea is typically a long-term treatment — many patients use their devices every night for years or decades. This long-duration use profile is precisely what makes the lung cancer connection so serious. A person who used a degrading Philips device for ten years of nightly use experienced approximately 29,000 hours of potential foam particle and VOC exposure. That is a fundamentally different exposure profile than a short-term or occasional user.

Heavy, long-term users — particularly those who used high-pressure BiPAP settings, which move more air volume through the device and potentially carry more particles — face the highest cumulative exposure burden. The duration and intensity of your use is a central element of your legal claim.

The Non-Smoker Problem

Lung cancer is strongly associated with smoking, and defense attorneys will argue that any lung cancer in a former or current smoker is attributable to tobacco rather than CPAP foam exposure. This argument is addressable but requires careful medical and legal framing. Lung cancer in never-smokers is a particularly compelling case for CPAP foam attribution. For current or former smokers, the argument is that CPAP foam exposure was an additional independent or contributing cause — a theory that courts have accepted in other toxic exposure cases.

An attorney experienced in toxic exposure and product liability claims will know how to frame the causation argument given your specific smoking history and exposure timeline.

Documenting a CPAP-Related Lung Cancer Claim

Strong documentation for a lung cancer claim includes: complete device use records (DME provider records, device serial number, prescription history), chest imaging from throughout your years of device use if available (baseline chest X-rays from physical exams are valuable), your lung cancer diagnosis and pathology records, and records of any respiratory symptoms you reported during your years of device use. The earlier in your use history that you reported symptoms, the stronger the timeline connection.

If you've already been diagnosed with lung cancer and used a Philips CPAP device, speaking with an attorney now is the most important step — before records become unavailable and while your memory of your device use history is current.